Gsa Capital Partners LLP Zomedica Corp. Transaction History

Gsa Capital Partners LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$0.12 - $0.18 $330,106 - $495,159	2,750,887 Added 1122.87%	2,995,874 $438,000
Q1 2024 May 03, 2024	BUY	$0.12 - $0.19 $29,398 - $46,547	244,987 New	244,987 $36,000
Q2 2022 Aug 09, 2022	BUY	$0.2 - $0.34 $8,884 - $15,103	44,421 Added 3.62%	1,272,480 $280,000
Q1 2022 May 11, 2022	BUY	$0.28 - $0.4 $8,785 - $12,550	31,377 Added 2.62%	1,228,059 $414,000
Q4 2021 Feb 14, 2022	BUY	$0.31 - $0.58 $370,971 - $694,075	1,196,682 New	1,196,682 $367,000
Q3 2021 Nov 12, 2021	SELL	$0.46 - $0.81 $47,486 - $83,617	-103,232 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$0.72 - $1.46 $74,327 - $150,718	103,232 New	103,232 $86,000

80.9M

Ticker ZOM
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 979,950,016
Market Cap $127M
Description
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.